Attached files
| file | filename |
|---|---|
| EX-16.1 - EX-16.1 - DTHERA SCIENCES | dthera_8ka-ex1601.htm |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 7, 2017
DTHERA SCIENCES
(Exact Name of Registrant as Specified in Charter)
| Nevada | 333-191175 | 90-0925768 |
| (State or Other Jurisdiction of Incorporation) | Commission File Number | (IRS Employer Identification No.) |
| 7310 Miramar Rd., San Diego, CA | 92126 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (858) 215-6360
_____________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Explanatory Note: On April 13, 2017, Dthera Sciences (the “Company”) filed a Current Report on Form 8-K. This Amendment to that Current Report is filed to provide Exhibit 16.1 to that Current Report.
| ITEM 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit No. | Description | |
| 16.1 | Letter from SG |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dthera Sciences | ||
| Date: April 17, 2017 | By: | /s/ Edward Cox |
Name: Title: |
Edward Cox Chief Executive Officer | |